Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Antiasthmatic Drug Market Growth (Status and Outlook) 2022-2028

  • LP 4910650
  • 120 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Antiasthmatic Drug will have significant change from previous year. According to our (LP Information) latest study, the global Antiasthmatic Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Antiasthmatic Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Antiasthmatic Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Antiasthmatic Drug market, reaching US$ million by the year 2028. As for the Europe Antiasthmatic Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Antiasthmatic Drug players cover Novartis AG, GlaxoSmithKline, ABC Farmaceutici Spa, and AstraZeneca, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Antiasthmatic Drug market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Bronchodilators

Anti-allergic Antiasthmatic

Anti-inflammatory Antiasthmatic

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Need for Acute Attack of Asthma

Treatment of Chronic Asthma

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Novartis AG

GlaxoSmithKline

ABC Farmaceutici Spa

AstraZeneca

Teva Pharmaceutical Industries Ltd

Mundipharma Pharmaceuticals Ltd.

MSD

Daiichi Sankyo Company Limited

Chiesi GmbH

Kyorin Pharmaceutical Co.,Ltd.

Kissei Pharmaceutical Co.Ltd.

Ruiyang Pharmaceutical Co., Ltd

Chiesi Pharmaceutical (Shangai) Co., Ltd

Fuhe Group

Lunan Pharmaceutical Group Co., Ltd

Chengdu Huayu Pharmaceutical Co., Ltd

Kaifeng Kangnuo Pharmaceutical Co., Ltd

Akorn Pharmaceutical Co.Ltd.

Boehringer Ingelheim Pharma GmbH&Co.KG

Covis Pharmaceutical Inc

Roche

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Antiasthmatic Drug Market Size 2017-2028

2.1.2 Antiasthmatic Drug Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Antiasthmatic Drug Segment by Type

2.2.1 Bronchodilators

2.2.2 Anti-allergic Antiasthmatic

2.2.3 Anti-inflammatory Antiasthmatic

2.3 Antiasthmatic Drug Market Size by Type

2.3.1 Antiasthmatic Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Antiasthmatic Drug Market Size Market Share by Type (2017-2022)

2.4 Antiasthmatic Drug Segment by Application

2.4.1 Need for Acute Attack of Asthma

2.4.2 Treatment of Chronic Asthma

2.5 Antiasthmatic Drug Market Size by Application

2.5.1 Antiasthmatic Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Antiasthmatic Drug Market Size Market Share by Application (2017-2022)

3 Antiasthmatic Drug Market Size by Player

3.1 Antiasthmatic Drug Market Size Market Share by Players

3.1.1 Global Antiasthmatic Drug Revenue by Players (2020-2022)

3.1.2 Global Antiasthmatic Drug Revenue Market Share by Players (2020-2022)

3.2 Global Antiasthmatic Drug Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Antiasthmatic Drug by Regions

4.1 Antiasthmatic Drug Market Size by Regions (2017-2022)

4.2 Americas Antiasthmatic Drug Market Size Growth (2017-2022)

4.3 APAC Antiasthmatic Drug Market Size Growth (2017-2022)

4.4 Europe Antiasthmatic Drug Market Size Growth (2017-2022)

4.5 Middle East & Africa Antiasthmatic Drug Market Size Growth (2017-2022)

5 Americas

5.1 Americas Antiasthmatic Drug Market Size by Country (2017-2022)

5.2 Americas Antiasthmatic Drug Market Size by Type (2017-2022)

5.3 Americas Antiasthmatic Drug Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Antiasthmatic Drug Market Size by Region (2017-2022)

6.2 APAC Antiasthmatic Drug Market Size by Type (2017-2022)

6.3 APAC Antiasthmatic Drug Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Antiasthmatic Drug by Country (2017-2022)

7.2 Europe Antiasthmatic Drug Market Size by Type (2017-2022)

7.3 Europe Antiasthmatic Drug Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Antiasthmatic Drug by Region (2017-2022)

8.2 Middle East & Africa Antiasthmatic Drug Market Size by Type (2017-2022)

8.3 Middle East & Africa Antiasthmatic Drug Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Antiasthmatic Drug Market Forecast

10.1 Global Antiasthmatic Drug Forecast by Regions (2023-2028)

10.1.1 Global Antiasthmatic Drug Forecast by Regions (2023-2028)

10.1.2 Americas Antiasthmatic Drug Forecast

10.1.3 APAC Antiasthmatic Drug Forecast

10.1.4 Europe Antiasthmatic Drug Forecast

10.1.5 Middle East & Africa Antiasthmatic Drug Forecast

10.2 Americas Antiasthmatic Drug Forecast by Country (2023-2028)

10.2.1 United States Antiasthmatic Drug Market Forecast

10.2.2 Canada Antiasthmatic Drug Market Forecast

10.2.3 Mexico Antiasthmatic Drug Market Forecast

10.2.4 Brazil Antiasthmatic Drug Market Forecast

10.3 APAC Antiasthmatic Drug Forecast by Region (2023-2028)

10.3.1 China Antiasthmatic Drug Market Forecast

10.3.2 Japan Antiasthmatic Drug Market Forecast

10.3.3 Korea Antiasthmatic Drug Market Forecast

10.3.4 Southeast Asia Antiasthmatic Drug Market Forecast

10.3.5 India Antiasthmatic Drug Market Forecast

10.3.6 Australia Antiasthmatic Drug Market Forecast

10.4 Europe Antiasthmatic Drug Forecast by Country (2023-2028)

10.4.1 Germany Antiasthmatic Drug Market Forecast

10.4.2 France Antiasthmatic Drug Market Forecast

10.4.3 UK Antiasthmatic Drug Market Forecast

10.4.4 Italy Antiasthmatic Drug Market Forecast

10.4.5 Russia Antiasthmatic Drug Market Forecast

10.5 Middle East & Africa Antiasthmatic Drug Forecast by Region (2023-2028)

10.5.1 Egypt Antiasthmatic Drug Market Forecast

10.5.2 South Africa Antiasthmatic Drug Market Forecast

10.5.3 Israel Antiasthmatic Drug Market Forecast

10.5.4 Turkey Antiasthmatic Drug Market Forecast

10.5.5 GCC Countries Antiasthmatic Drug Market Forecast

10.6 Global Antiasthmatic Drug Forecast by Type (2023-2028)

10.7 Global Antiasthmatic Drug Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Novartis AG

11.1.1 Novartis AG Company Information

11.1.2 Novartis AG Antiasthmatic Drug Product Offered

11.1.3 Novartis AG Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Novartis AG Main Business Overview

11.1.5 Novartis AG Latest Developments

11.2 GlaxoSmithKline

11.2.1 GlaxoSmithKline Company Information

11.2.2 GlaxoSmithKline Antiasthmatic Drug Product Offered

11.2.3 GlaxoSmithKline Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 GlaxoSmithKline Main Business Overview

11.2.5 GlaxoSmithKline Latest Developments

11.3 ABC Farmaceutici Spa

11.3.1 ABC Farmaceutici Spa Company Information

11.3.2 ABC Farmaceutici Spa Antiasthmatic Drug Product Offered

11.3.3 ABC Farmaceutici Spa Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 ABC Farmaceutici Spa Main Business Overview

11.3.5 ABC Farmaceutici Spa Latest Developments

11.4 AstraZeneca

11.4.1 AstraZeneca Company Information

11.4.2 AstraZeneca Antiasthmatic Drug Product Offered

11.4.3 AstraZeneca Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 AstraZeneca Main Business Overview

11.4.5 AstraZeneca Latest Developments

11.5 Teva Pharmaceutical Industries Ltd

11.5.1 Teva Pharmaceutical Industries Ltd Company Information

11.5.2 Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Product Offered

11.5.3 Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Teva Pharmaceutical Industries Ltd Main Business Overview

11.5.5 Teva Pharmaceutical Industries Ltd Latest Developments

11.6 Mundipharma Pharmaceuticals Ltd.

11.6.1 Mundipharma Pharmaceuticals Ltd. Company Information

11.6.2 Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Product Offered

11.6.3 Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Mundipharma Pharmaceuticals Ltd. Main Business Overview

11.6.5 Mundipharma Pharmaceuticals Ltd. Latest Developments

11.7 MSD

11.7.1 MSD Company Information

11.7.2 MSD Antiasthmatic Drug Product Offered

11.7.3 MSD Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 MSD Main Business Overview

11.7.5 MSD Latest Developments

11.8 Daiichi Sankyo Company Limited

11.8.1 Daiichi Sankyo Company Limited Company Information

11.8.2 Daiichi Sankyo Company Limited Antiasthmatic Drug Product Offered

11.8.3 Daiichi Sankyo Company Limited Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Daiichi Sankyo Company Limited Main Business Overview

11.8.5 Daiichi Sankyo Company Limited Latest Developments

11.9 Chiesi GmbH

11.9.1 Chiesi GmbH Company Information

11.9.2 Chiesi GmbH Antiasthmatic Drug Product Offered

11.9.3 Chiesi GmbH Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Chiesi GmbH Main Business Overview

11.9.5 Chiesi GmbH Latest Developments

11.10 Kyorin Pharmaceutical Co.,Ltd.

11.10.1 Kyorin Pharmaceutical Co.,Ltd. Company Information

11.10.2 Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Product Offered

11.10.3 Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Kyorin Pharmaceutical Co.,Ltd. Main Business Overview

11.10.5 Kyorin Pharmaceutical Co.,Ltd. Latest Developments

11.11 Kissei Pharmaceutical Co.Ltd.

11.11.1 Kissei Pharmaceutical Co.Ltd. Company Information

11.11.2 Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Product Offered

11.11.3 Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Kissei Pharmaceutical Co.Ltd. Main Business Overview

11.11.5 Kissei Pharmaceutical Co.Ltd. Latest Developments

11.12 Ruiyang Pharmaceutical Co., Ltd

11.12.1 Ruiyang Pharmaceutical Co., Ltd Company Information

11.12.2 Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Product Offered

11.12.3 Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Ruiyang Pharmaceutical Co., Ltd Main Business Overview

11.12.5 Ruiyang Pharmaceutical Co., Ltd Latest Developments

11.13 Chiesi Pharmaceutical (Shangai) Co., Ltd

11.13.1 Chiesi Pharmaceutical (Shangai) Co., Ltd Company Information

11.13.2 Chiesi Pharmaceutical (Shangai) Co., Ltd Antiasthmatic Drug Product Offered

11.13.3 Chiesi Pharmaceutical (Shangai) Co., Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Chiesi Pharmaceutical (Shangai) Co., Ltd Main Business Overview

11.13.5 Chiesi Pharmaceutical (Shangai) Co., Ltd Latest Developments

11.14 Fuhe Group

11.14.1 Fuhe Group Company Information

11.14.2 Fuhe Group Antiasthmatic Drug Product Offered

11.14.3 Fuhe Group Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Fuhe Group Main Business Overview

11.14.5 Fuhe Group Latest Developments

11.15 Lunan Pharmaceutical Group Co., Ltd

11.15.1 Lunan Pharmaceutical Group Co., Ltd Company Information

11.15.2 Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Product Offered

11.15.3 Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Lunan Pharmaceutical Group Co., Ltd Main Business Overview

11.15.5 Lunan Pharmaceutical Group Co., Ltd Latest Developments

11.16 Chengdu Huayu Pharmaceutical Co., Ltd

11.16.1 Chengdu Huayu Pharmaceutical Co., Ltd Company Information

11.16.2 Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Product Offered

11.16.3 Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Chengdu Huayu Pharmaceutical Co., Ltd Main Business Overview

11.16.5 Chengdu Huayu Pharmaceutical Co., Ltd Latest Developments

11.17 Kaifeng Kangnuo Pharmaceutical Co., Ltd

11.17.1 Kaifeng Kangnuo Pharmaceutical Co., Ltd Company Information

11.17.2 Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Product Offered

11.17.3 Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Kaifeng Kangnuo Pharmaceutical Co., Ltd Main Business Overview

11.17.5 Kaifeng Kangnuo Pharmaceutical Co., Ltd Latest Developments

11.18 Akorn Pharmaceutical Co.Ltd.

11.18.1 Akorn Pharmaceutical Co.Ltd. Company Information

11.18.2 Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Product Offered

11.18.3 Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Akorn Pharmaceutical Co.Ltd. Main Business Overview

11.18.5 Akorn Pharmaceutical Co.Ltd. Latest Developments

11.19 Boehringer Ingelheim Pharma GmbH&Co.KG

11.19.1 Boehringer Ingelheim Pharma GmbH&Co.KG Company Information

11.19.2 Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Product Offered

11.19.3 Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Boehringer Ingelheim Pharma GmbH&Co.KG Main Business Overview

11.19.5 Boehringer Ingelheim Pharma GmbH&Co.KG Latest Developments

11.20 Covis Pharmaceutical Inc

11.20.1 Covis Pharmaceutical Inc Company Information

11.20.2 Covis Pharmaceutical Inc Antiasthmatic Drug Product Offered

11.20.3 Covis Pharmaceutical Inc Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 Covis Pharmaceutical Inc Main Business Overview

11.20.5 Covis Pharmaceutical Inc Latest Developments

11.21 Roche

11.21.1 Roche Company Information

11.21.2 Roche Antiasthmatic Drug Product Offered

11.21.3 Roche Antiasthmatic Drug Revenue, Gross Margin and Market Share (2020-2022)

11.21.4 Roche Main Business Overview

11.21.5 Roche Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Antiasthmatic Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Bronchodilators

Table 3. Major Players of Anti-allergic Antiasthmatic

Table 4. Major Players of Anti-inflammatory Antiasthmatic

Table 5. Antiasthmatic Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global Antiasthmatic Drug Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global Antiasthmatic Drug Market Size Market Share by Type (2017-2022)

Table 8. Antiasthmatic Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Antiasthmatic Drug Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global Antiasthmatic Drug Market Size Market Share by Application (2017-2022)

Table 11. Global Antiasthmatic Drug Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global Antiasthmatic Drug Revenue Market Share by Player (2020-2022)

Table 13. Antiasthmatic Drug Key Players Head office and Products Offered

Table 14. Antiasthmatic Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Antiasthmatic Drug Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global Antiasthmatic Drug Market Size Market Share by Regions (2017-2022)

Table 19. Americas Antiasthmatic Drug Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas Antiasthmatic Drug Market Size Market Share by Country (2017-2022)

Table 21. Americas Antiasthmatic Drug Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas Antiasthmatic Drug Market Size Market Share by Type (2017-2022)

Table 23. Americas Antiasthmatic Drug Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas Antiasthmatic Drug Market Size Market Share by Application (2017-2022)

Table 25. APAC Antiasthmatic Drug Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC Antiasthmatic Drug Market Size Market Share by Region (2017-2022)

Table 27. APAC Antiasthmatic Drug Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC Antiasthmatic Drug Market Size Market Share by Type (2017-2022)

Table 29. APAC Antiasthmatic Drug Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC Antiasthmatic Drug Market Size Market Share by Application (2017-2022)

Table 31. Europe Antiasthmatic Drug Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe Antiasthmatic Drug Market Size Market Share by Country (2017-2022)

Table 33. Europe Antiasthmatic Drug Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe Antiasthmatic Drug Market Size Market Share by Type (2017-2022)

Table 35. Europe Antiasthmatic Drug Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe Antiasthmatic Drug Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa Antiasthmatic Drug Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa Antiasthmatic Drug Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa Antiasthmatic Drug Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Antiasthmatic Drug Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa Antiasthmatic Drug Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Antiasthmatic Drug Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of Antiasthmatic Drug

Table 44. Key Market Challenges & Risks of Antiasthmatic Drug

Table 45. Key Industry Trends of Antiasthmatic Drug

Table 46. Global Antiasthmatic Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global Antiasthmatic Drug Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global Antiasthmatic Drug Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global Antiasthmatic Drug Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global Antiasthmatic Drug Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global Antiasthmatic Drug Market Size Market Share Forecast by Application (2023-2028)

Table 52. Novartis AG Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 53. Novartis AG Antiasthmatic Drug Product Offered

Table 54. Novartis AG Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. Novartis AG Main Business

Table 56. Novartis AG Latest Developments

Table 57. GlaxoSmithKline Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 58. GlaxoSmithKline Antiasthmatic Drug Product Offered

Table 59. GlaxoSmithKline Main Business

Table 60. GlaxoSmithKline Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. GlaxoSmithKline Latest Developments

Table 62. ABC Farmaceutici Spa Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 63. ABC Farmaceutici Spa Antiasthmatic Drug Product Offered

Table 64. ABC Farmaceutici Spa Main Business

Table 65. ABC Farmaceutici Spa Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. ABC Farmaceutici Spa Latest Developments

Table 67. AstraZeneca Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 68. AstraZeneca Antiasthmatic Drug Product Offered

Table 69. AstraZeneca Main Business

Table 70. AstraZeneca Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. AstraZeneca Latest Developments

Table 72. Teva Pharmaceutical Industries Ltd Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 73. Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Product Offered

Table 74. Teva Pharmaceutical Industries Ltd Main Business

Table 75. Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Teva Pharmaceutical Industries Ltd Latest Developments

Table 77. Mundipharma Pharmaceuticals Ltd. Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 78. Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Product Offered

Table 79. Mundipharma Pharmaceuticals Ltd. Main Business

Table 80. Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Mundipharma Pharmaceuticals Ltd. Latest Developments

Table 82. MSD Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 83. MSD Antiasthmatic Drug Product Offered

Table 84. MSD Main Business

Table 85. MSD Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. MSD Latest Developments

Table 87. Daiichi Sankyo Company Limited Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 88. Daiichi Sankyo Company Limited Antiasthmatic Drug Product Offered

Table 89. Daiichi Sankyo Company Limited Main Business

Table 90. Daiichi Sankyo Company Limited Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Daiichi Sankyo Company Limited Latest Developments

Table 92. Chiesi GmbH Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 93. Chiesi GmbH Antiasthmatic Drug Product Offered

Table 94. Chiesi GmbH Main Business

Table 95. Chiesi GmbH Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Chiesi GmbH Latest Developments

Table 97. Kyorin Pharmaceutical Co.,Ltd. Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 98. Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Product Offered

Table 99. Kyorin Pharmaceutical Co.,Ltd. Main Business

Table 100. Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Kyorin Pharmaceutical Co.,Ltd. Latest Developments

Table 102. Kissei Pharmaceutical Co.Ltd. Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 103. Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Product Offered

Table 104. Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Kissei Pharmaceutical Co.Ltd. Main Business

Table 106. Kissei Pharmaceutical Co.Ltd. Latest Developments

Table 107. Ruiyang Pharmaceutical Co., Ltd Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 108. Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Product Offered

Table 109. Ruiyang Pharmaceutical Co., Ltd Main Business

Table 110. Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 111. Ruiyang Pharmaceutical Co., Ltd Latest Developments

Table 112. Chiesi Pharmaceutical (Shangai) Co., Ltd Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 113. Chiesi Pharmaceutical (Shangai) Co., Ltd Antiasthmatic Drug Product Offered

Table 114. Chiesi Pharmaceutical (Shangai) Co., Ltd Main Business

Table 115. Chiesi Pharmaceutical (Shangai) Co., Ltd Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. Chiesi Pharmaceutical (Shangai) Co., Ltd Latest Developments

Table 117. Fuhe Group Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 118. Fuhe Group Antiasthmatic Drug Product Offered

Table 119. Fuhe Group Main Business

Table 120. Fuhe Group Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 121. Fuhe Group Latest Developments

Table 122. Lunan Pharmaceutical Group Co., Ltd Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 123. Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Product Offered

Table 124. Lunan Pharmaceutical Group Co., Ltd Main Business

Table 125. Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 126. Lunan Pharmaceutical Group Co., Ltd Latest Developments

Table 127. Chengdu Huayu Pharmaceutical Co., Ltd Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 128. Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Product Offered

Table 129. Chengdu Huayu Pharmaceutical Co., Ltd Main Business

Table 130. Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 131. Chengdu Huayu Pharmaceutical Co., Ltd Latest Developments

Table 132. Kaifeng Kangnuo Pharmaceutical Co., Ltd Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 133. Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Product Offered

Table 134. Kaifeng Kangnuo Pharmaceutical Co., Ltd Main Business

Table 135. Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 136. Kaifeng Kangnuo Pharmaceutical Co., Ltd Latest Developments

Table 137. Akorn Pharmaceutical Co.Ltd. Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 138. Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Product Offered

Table 139. Akorn Pharmaceutical Co.Ltd. Main Business

Table 140. Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 141. Akorn Pharmaceutical Co.Ltd. Latest Developments

Table 142. Boehringer Ingelheim Pharma GmbH&Co.KG Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 143. Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Product Offered

Table 144. Boehringer Ingelheim Pharma GmbH&Co.KG Main Business

Table 145. Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 146. Boehringer Ingelheim Pharma GmbH&Co.KG Latest Developments

Table 147. Covis Pharmaceutical Inc Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 148. Covis Pharmaceutical Inc Antiasthmatic Drug Product Offered

Table 149. Covis Pharmaceutical Inc Main Business

Table 150. Covis Pharmaceutical Inc Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 151. Covis Pharmaceutical Inc Latest Developments

Table 152. Roche Details, Company Type, Antiasthmatic Drug Area Served and Its Competitors

Table 153. Roche Antiasthmatic Drug Product Offered

Table 154. Roche Antiasthmatic Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 155. Roche Main Business

Table 156. Roche Latest Developments

List of Figures

Figure 1. Antiasthmatic Drug Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Antiasthmatic Drug Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Antiasthmatic Drug Market Size Market Share by Type in 2021

Figure 7. Antiasthmatic Drug in Need for Acute Attack of Asthma

Figure 8. Global Antiasthmatic Drug Market: Need for Acute Attack of Asthma (2017-2022) & ($ Millions)

Figure 9. Antiasthmatic Drug in Treatment of Chronic Asthma

Figure 10. Global Antiasthmatic Drug Market: Treatment of Chronic Asthma (2017-2022) & ($ Millions)

Figure 11. Global Antiasthmatic Drug Market Size Market Share by Application in 2021

Figure 12. Global Antiasthmatic Drug Revenue Market Share by Player in 2021

Figure 13. Global Antiasthmatic Drug Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Antiasthmatic Drug Market Size 2017-2022 ($ Millions)

Figure 15. APAC Antiasthmatic Drug Market Size 2017-2022 ($ Millions)

Figure 16. Europe Antiasthmatic Drug Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Antiasthmatic Drug Market Size 2017-2022 ($ Millions)

Figure 18. Americas Antiasthmatic Drug Value Market Share by Country in 2021

Figure 19. Americas Antiasthmatic Drug Consumption Market Share by Type in 2021

Figure 20. Americas Antiasthmatic Drug Market Size Market Share by Application in 2021

Figure 21. United States Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Antiasthmatic Drug Market Size Market Share by Region in 2021

Figure 26. APAC Antiasthmatic Drug Market Size Market Share by Application in 2021

Figure 27. China Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Antiasthmatic Drug Market Size Market Share by Country in 2021

Figure 34. Europe Antiasthmatic Drug Market Size Market Share by Type in 2021

Figure 35. Europe Antiasthmatic Drug Market Size Market Share by Application in 2021

Figure 36. Germany Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Antiasthmatic Drug Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Antiasthmatic Drug Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Antiasthmatic Drug Market Size Market Share by Application in 2021

Figure 44. Egypt Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Antiasthmatic Drug Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 50. APAC Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 51. Europe Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 53. United States Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 54. Canada Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 57. China Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 58. Japan Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 59. Korea Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 61. India Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 62. Australia Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 63. Germany Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 64. France Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 65. UK Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 66. Italy Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 67. Russia Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 68. Spain Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 71. Israel Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Antiasthmatic Drug Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390